The NEJM has published results of a real-world efficacty trial showing that COVID infected children with the multisystem inflammatory syndrome in children (MIS-C) respond better to initial IVIG plus glucocorticoids (than IVIG alone) which was associated with less subsequent cardiovascular complications.
Dr. John Cush RheumNow
5 years 3 months ago
Comparative Effectiveness: Registries or Real Life?
Dr. Jonathan Kay reviews abstracts presented at #EULAR2021.
https://t.co/rvuu3ouWTP https://t.co/dcgluJretH
Dr. John Cush RheumNow
5 years 3 months ago
Trial Design for Better Decision-making Using JAKi: Dr. Kerschbaumer and Dr. Studenic
https://t.co/NtXZEJM4vg https://t.co/QOaxBPebz6
Dr. John Cush RheumNow
5 years 3 months ago
Problems at the FDA
https://t.co/mkCrYAVudo https://t.co/fAE1pNSg0q
NEJM has published the results of an observational trial wherein tofacitinib given to patients hospitalized with Covid-19 pneumonia, was shown to significantly lower risk of death or respiratory failure.
Dr. John Cush RheumNow
5 years 3 months ago
Download the latest RheumNow podcast. Available on Soundcloud and where you get you podcasts.
https://t.co/uPNyVzFaZF https://t.co/gzIZpsinz9
The potential transition from psoriasis (PsO) to psoriatic arthritis (PsA) has not been a strong focus for several years but is gaining momentum.
Dr. John Cush RheumNow
5 years 3 months ago
Is Rituximab and Belimumab the Combination to Beat Lupus?
Dr. Eric Dein ( @ericdeinmd ) shares learnings from #EULAR2021.
https://t.co/r4aNG7KR5h https://t.co/2kedsCL904
Dr. John Cush RheumNow
5 years 3 months ago
Don't Kill the Krill!
Dr. Kathryn Dao ( @KDAO2011) reviews abstract POS0276 regarding the efficacy of krill oil in knee OA, presented at the virtual EULAR 2021 meeting.
https://t.co/gX2hivyCs2 https://t.co/QaU7A7gM8j
Dr. John Cush RheumNow
5 years 3 months ago
Watch: Lupus and the Economic Burden of Mental Health
https://t.co/Ag3oz6U4mF https://t.co/cA5LmGRImf
Dr. John Cush RheumNow
5 years 3 months ago
Should we treat to target ourselves?
Dr. David Liew ( @drdavidliew ) shares learnings from #EULAR2021.
https://t.co/divGxNku6a https://t.co/UBBH0QehY1
Dr. John Cush RheumNow
5 years 3 months ago
Serious Infection Risk from the Filgotinib Drug Development Program
Dr. Paul Studenic talks with Dr. James Galloway about abstract OP0126 presented at the virtual EULAR 2021 meeting.
https://t.co/ymd8odsjAD https://t.co/d9fXGdmgOn
Dr. John Cush RheumNow
5 years 3 months ago
What's the impact of RA on male fertility?
Dr. Aurelie Njam shares new data provided at #EULAR2021.
https://t.co/AHwhyLiwD0 https://t.co/pFKoADZ2sh
